Luizza 1/20 Tablet
Product Images NDC 70700-313

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Luizza 1/20 (NDC 70700-313). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Xiromed, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ethinyl Estradiol And Norethindrone Acetate Structural Formulas (Image 01)

Ethinyl Estradiol And Norethindrone Acetate Structural Formulas (Image 01)
This is a description of two pharmaceutical compounds: Ethinyl Estradiol and Norethindrone Acetate. Ethinyl Estradiol has a molecular weight of 296.40 g/mol and the chemical formula C20H24O2. Norethindrone Acetate has a molecular weight of 340.46 g/mol and the chemical formula C22H28O3. These compounds are commonly used in contraceptives and hormone replacement therapy.*
FDA Label Image

Table Ii: Circulatory Disease Mortality Rates Per 100,000 Woman Years By Age, Smoking Status And Oral Contraceptive Use (Image 02)

Table Ii: Circulatory Disease Mortality Rates Per 100,000 Woman Years By Age, Smoking Status And Oral Contraceptive Use (Image 02)
This text provides information on mortality rates among different age groups of ever-users and controls, categorized by smokers and non-smokers. Data includes the number of deaths per 100 individuals for age groups 15-24, 25-34, 35-44, and 45+. Reference: P.M. Layde and V. Beral, Reference 18.*
FDA Label Image

Figure 1: Relevant Studies Of Risk Of Breast Cancer With Combined Oral Contraceptives (Image 03)

Figure 1: Relevant Studies Of Risk Of Breast Cancer With Combined Oral Contraceptives (Image 03)
The text evaluates the impact of ever using combined oral contraceptives (COC) compared to never using them on the risk of various health outcomes. Different studies provide estimates such as odds ratios (OR), relative risks (RR), and hazard ratios (HR). The data suggest varying levels of risk associated with COC use, with some studies showing no significant difference and others indicating slightly increased or decreased risks. The studies include the NICHD Women's Care Study, French E3N cohort Study, Shanghai Women's Health Study, The Nurses' Health Study II, Oxford Family Planning Study, and Danish Sex Hormone Register Study. The analysis compares the risks of current COC use versus never-use among females.*
FDA Label Image

Instructions For Use Figure 1 (Image 04)

Instructions For Use Figure 1 (Image 04)
This is a text regarding a birth control pill pack, Luizza™1/20 (Norethindrone Acetate and Ethinyl Estradiol Tablets USP, 1 mg/20 mcg), which provides instructions for both Sunday starters and Day-1 starters. It includes a day label strip for non-Sunday starters and indicates to take pills from left to right each week. The pack contains medications that need to be stored at 20°to 25°C (68°to 77°F).*
FDA Label Image

Instructions For Use Figure 2 (Image 05)

Instructions For Use Figure 2 (Image 05)
This text provides instructions on how to track the start of your period using a day label strip that corresponds to the days of the week. It suggests placing the label strip over the area with preprinted days of the week, starting on a Sunday. This method is helpful for tracking menstrual cycles and can be adjusted if the period starts on a different day.*
FDA Label Image

Instructions For Use Figure 3 (Image 06)

Instructions For Use Figure 3 (Image 06)
This text provides instructions for starting birth control pills, specifically for day-1 starters. It includes information on where to place the day label strip and which direction to take the pills each week. Additionally, it mentions the specific brand and content of the birth control pills, "Luizza™ 120 Norethindrone Acetate and Ethinyl Estradiol Tablets 1 mg/20 mcg". The NDC number for the tablets is also included.*
FDA Label Image

Instructions For Use Figure 4 (Image 07)

Instructions For Use Figure 4 (Image 07)
This text provides instructions on how to mark the first day of your period on a calendar. It suggests labeling the day strip that starts with the first day of your period and marking the days of the week starting with Sunday. If the first day of your period falls on a Sunday, a step can be skipped.*
FDA Label Image

Norethindrone Acetate And Ethinyl Estradiol Tablets Label (Image 08)

Norethindrone Acetate And Ethinyl Estradiol Tablets Label (Image 08)
This text appears to be a description of Luizza™ 1/20, which is a combination oral contraceptive containing Norethindrone Acetate and Ethinyl Estradiol Tablets, USP. The product is designed to prevent pregnancy but does not offer protection against HIV infection (AIDS) or other sexually transmitted diseases. Each pouch contains one blister pack with 21 tablets of the contraceptive medication.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.